Fig. 6From: Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium studySerum levels of bacterially produced uremic toxins. ESRD patients showed significantly increased levels of (a) p-cresyl sulfate P < 0.0001 (Kruskal-Wallis test followed by Dunn’s multiple comparisons test.) and (b) indoxyl sulfate P < 0.0001 (Kruskal-Wallis test followed by Dunn’s multiple comparisons test.). N = 7–12 in individual groups. Box and whisker plots illustrate median (line within the box) and minimum and maximum values (whiskers)Back to article page